10 Stocks Losing Big

Page 9 of 9

1. ESSA Pharma Inc. (NASDAQ:EPIX)

ESSA Pharma nosedived by 66.39 percent on Tuesday to end at $0.2631 apiece as investors sold off positions following the payment of $80 million to its shareholders as part of its business shutdown.

In a statement, ESSA Pharma Inc. (NASDAQ:EPIX) said it returned around $1.69 per share to shareholders as of August 22 record. It also corrected the ex-dividend date to August 22, instead of August 25 as it had earlier announced.

The transaction was in line with ESSA Pharma Inc.’s (NASDAQ:EPIX) planned merger with XenoTherapeutics, Inc., under which the latter will acquire all of its issued and outstanding shares.

Under the terms of the agreement, shareholders of ESSA Pharma Inc. (NASDAQ:EPIX) will receive a cash payment that will be determined based on its cash balance at closing after deducting certain transaction costs, a reserve for liabilities and legal expenses, and a transaction fee.

Additionally, each shareholder will receive one non-transferable contingent value right for each share, which will entitle the shareholder to receive a pro rata portion of up to $2.95 million or $0.06 per CVR within 18 months following the transaction.

While we acknowledge the potential of EPIX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than EPIX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

Page 9 of 9